skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good Morning Peter and Team,
Now with the Paladin / Endo deal done (what a pleasant outcome) my question is about the spinoff: Knight Therapeudics (GUD- TSXV). I would like to continue to partner directly with Jonathan Goodman and his team. Do you think it would be a good idea to purchase additional shares of GUD when they begin trading on March 3rd ??? Thanks for your help as always. DL
Read Answer Asked by Dennis on February 28, 2014
Q: Keg Restaurants Royalty Fund KEG.UN is experiencing severe damage to the stock price (15.58) as it has plunged to just above the 200 day MA (15.15) ... is this just due to losing money in Q4 ? or is there more to the story... at 8¢/ month , the yield is over 6%
... is this a BUY ?
Read Answer Asked by Thomas on February 28, 2014
Q: Hello
What do you think of Phoenix Energy Services recent results. They seem to grow consistently and are diversifying international. I don't know why they don't seem to be followed. Thank you again for your superior service . Mike
Read Answer Asked by Mike on February 28, 2014
Q: As a shareholder of Constellation Software (CSU), I wonder why they don't do a stock split this would encourage more small shareholders to buy in, not many people want to buy 10 or 15 shares. Their volume each day is very low and it seems that this can allow a few shareholders to affect the stock price. Recently on no news other than some analyst from RBC downgrading the company from a buy to a hold the stock had a large drop. Would you have any comments? Thanks
Read Answer Asked by Bill on February 28, 2014
Q: I am interested in any comments that you might have on ZDV -BMO Canadian Dividend ETF. My interest is mainly for solid and growing income. This ETF has a higher dividend than some similar ETFs. Reading the questions and your responses is indeed a great education. Thank you. Len
Read Answer Asked by Len on February 28, 2014
Q: You answered a question from Ralph about using HFR as a "safe place to park excess cash sitting in a discount brokerage RRSP, perhaps for a few months, while waiting to invest it in the market". Outside an RSP I have used HFP to park cash. It yields 3.25%, receives benefits of dividend tax credit. It is not a big trader so there is a bit of a bid/ask spread, but I have found if I am able to wait a day or two I have always been able to get for equal to or better than my buy price. Any caveats?
Read Answer Asked by Douglas on February 28, 2014
Q: Hi Peter and team,

Understand you don't follow the US Equities that closely but I have owned Disney for some time but its valuation seems a little overdone here and I was considering the switch to TWX since it is trading at a much cheaper multiple. My question is will the sell off of the cable division impact TWX overall and do you think this is worth the switch?
Read Answer Asked by kelly on February 28, 2014
Q: Hi Peter
Thanks for your recent newsletter my favorite read of the day. We bought Altus Group (AIF) because of an answer to a question from back in Aug. We did some research and have being holding it since. It had a good jump this week. Would you say it is still a buy or just a hold. It makes up less than 1% of our portfolio. Thanks for groups time and effort.
Read Answer Asked by jeffrey on February 28, 2014
Q: Hi 5i
I am getting pummelled on Argent Energy. Is it time to jump ship or should I wait for it to recover to a better price?
Thanks, Kevin
Read Answer Asked by Kevin on February 28, 2014
Q: hello, i bought Jive software @ $10.00 a share. do have an outlook on jive ? symbol i "JIVE" on nasdaq. thanks.
Read Answer Asked by Brian on February 28, 2014
Q: I still hold my Paladin PLB shares and wonder what you think of Endo's ENDP results. Is this good, bad, or neutral? Wondering why they guided lower for 2014 after the Paladin acquisition. Is it time to sell Paladin?

Endo Health beats by $0.04, misses on revs; guides FY14 EPS below consensus, revs in-line (ENDP) : Reports Q4 (Dec) earnings of $0.96 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $0.92; revenues fell 26.8% year/year to $548.9 mln vs the $620.71 mln consensus.
Read Answer Asked by Gordon on February 28, 2014
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!